Eva
Bandres Elizalde
Ikertzailea 2004-(e)ra arte
German Cancer Research Center
Heidelberg, AlemaniaGerman Cancer Research Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET
Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820